Back to results
US 2019/0240234 A1Published application
Pharmaceutical composition for treatment of increased intraocular pressure
AssigneeNovaliq GmbH
InventorsBastian THEISINGER, Sonja THEISINGER, Bernhard GÜNTHER
Life of this patent
Estimating the term…
Abstract
The invention provides novel pharmaceutical compositions based on semifluorinated alkanes which are useful as carriers for a broad range of active ingredients. Preferred active ingredients include poorly water-soluble prostaglandin analogues. The invention further provides kits comprising such compositions.
Claims18
1-15. (canceled)
A pharmaceutical composition comprising:
- (a) a therapeutically effective amount of a poorly water-soluble prostaglandin analogue selected from the group consisting of latanoprost, bimatoprost, tafluprost, travoprost and unoprostone, and
- (b) a liquid vehicle comprising a semifluorinated alkane selected from F4H5, F4H6, F6H6 and F6H8;
- wherein the composition is substantially free of water and free of a preservative, and wherein the composition is formulated as a solution, emulsion or suspension.
Dependencies are inferred from the claim text.